Jul 27, 2024, 22:17
A blood test that may predict if people with relapsed MM are going to respond well to CAR-T immunotherapy – Weill Cornell Medicine
Weill Cornell Medicine shared on X:
“A blood test that measures the number of lymphocytes may predict if people with relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new multi-institutional study led by Weill Department of Medicine.
Full story here.”
Source: Weill Cornell Medicine/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 21:29
Aug 8, 2025, 21:08
Aug 8, 2025, 20:54
Aug 8, 2025, 20:18
Aug 8, 2025, 20:03
Aug 8, 2025, 19:51
Aug 8, 2025, 19:34